Relationship between VEGF, CA 15-3 and Ki-67 in Women with Early Stage Breast Cancer
, 2014 Vascular endothelial growth factor (VEGF) plays a critical role in angiogenesis. It may be a clinically useful indicator for diagnostic and prognostic evaluation in patients with several solid tumors, including ovarian cancer, hepatocellular carcinoma ...
LUMACHI, FRANCO +3 more
core
American Journal of Clinical Oncology, 1996 A total of 209 postsurgical breast cancer patients were prospectively monitored with simultaneous serum level estimations of CA 15,3, mucin-like carcinoma-associated antigen (MCA), tumor polypeptide antigen (TPA), and carcinoembryonic antigen (CEA); 141 (67.5%) were free of recurrence and 68 (32.5%) developed metastases during the follow-up.
Pectasides, Dimitrios +13 more
openaire +4 more sources
Validation of a Multivariate Serum Profile for Epithelial Ovarian Cancer Using a Prospective Multi-Site Collection [PDF]
, 2010 In previous studies we described the use of a retrospective collection of ovarian cancer and benign disease samples, in combination with a large set of multiplexed immunoassays and a multivariate pattern recognition algorithm, to develop an 11-biomarker ...
Brigitte E. Miller +20 more
core
Molecularly imprinted electrochemical sensor for the point-of-care detection of a breast cancer biomarker (CA 15-3) [PDF]
, 2018 The incidence of breast cancer has been increasing over the years. To control and monitor this disease several tumor biomarkers have been proposed for early diagnosis, patient follow-up and/or treatment guidance. The only serum breast cancer biomarker in
Nouws, Henri +9 more
core +1 more source
Tumor markers of breast cancer: New prospectives
Journal of Oncological Sciences, 2017 Tumor markers are substances produced by the tumors or by other cells of the body in response to cancer or certain benign conditions. Although most of these markers are made by the normal cells as well as by cancer cells, they are produced at much higher
Ahmed M. Kabel
doaj +1 more source
CA 549 as a Marker in Breast Cancer
The International Journal of Biological Markers, 1991 CA 549 is one of several carcinoma associated mucin antigens proposed as a breast cancer tumor marker. In this study, the performance characteristics of the CA 549 assay were validated and the clinical utility of the test was compared with that of other ...
A.M. Dnistrian +5 more
doaj +1 more source
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer
The International Journal of Biological Markers, 1995 In order to assess the utility of the tumor-associated antigen CA 72-4 in the diagnosis and monitoring of gastric cancer, this tumor marker was measured preoperatively in 718 patients.
F. Safi, V. Kuhns, H.G. Beger
doaj +1 more source
HUBUNGAN KADAR CANCER ANTIGEN 15-3 SERUM DENGAN DERAJAT HISTOPATOLOGI KARSINOMA PAYUDARA INVASIF TIDAK SPESIFIK [PDF]
, 2019 Karsinoma payudara invasif tidak spesifik terjadi pada 80% kasus kanker payudara. Gen Mucin 1( MUC1) yang mengkode ekspresi Cancer Antigen 15-3 (CA 15-3) serum diketahui memiliki fungsi sebagai onkoprotein.
Nasri, Lailaturrahmi
core +1 more source
Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?
The Turkish Journal of Gastroenterology, 2018 Objectives: This study aims to evaluate the serum tumor-associated antigen levels and the possible association between these markers and interstitial lung disease (ILD) or malignancy in rheumatoid arthritis (RA) patients.
Gökhan SARGIN +2 more
doaj
Correlation of Serum CA 15-3 with Pulmonary Function in Systemic Sclerosis and MCTD-Associated ILD
Journal of Clinical Rheumatology and ImmunologyBackground: ILD progression in systemic sclerosis (SSc) and MCTD is monitored on pulmonary function tests (PFTs), including forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO), along with HRCT.
Aashish Agrawal +5 more
doaj +1 more source